// App-Quantinova.ai

18736 : Relationship of PCSK9 With Measures of Vascular Disease and Global Risk in 1574 Individuals Enrolled in the FATE (Fireman And Their Endothelium) Study

Researchers

Presenter

  • Eva M Lonn

Principal Investigators

  • Marinda Fung

  • Todd J Anderson

Medical Centers

  • Univ of Calgary, Calgary, Canada

  • McMaster University, Hamilton, ON, Canada

  • St. Michael's Hosp, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Proprotein convertase subtilisin/kexin type 9

  • High sensitivity C-reactive protein

Drug/Treatment

  • Nitroglycerin

  • Adesitrin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved